Search results
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 23 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 20 hours agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 12 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 19 hours agoPfizer and BioNTech have denied infringement with both firms seeking the “revocation” of two Moderna...
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Morningstar· 2 days agoBioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally ...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 2 weeks ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 6 days agoPfizer stock is trading at a nine-year low as the drugmaker looks for its next big break after...
Transatlantic Trade | US and Europe – Week of August 9, 2021
The National Law Review· 2 weeks agoThe US Government also moved forward with approving the Pfizer/BioNTech and Moderna vaccines for a booster dose for immunocompromised ...
Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales?
Zacks via Yahoo Finance· 2 weeks agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks via Yahoo Finance· 2 weeks agoTo extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple...